Free Coronavirus / COVID-19 CME

  • FREE

    Vaccine hesitancy and denial: A problem for the ages coming into sharp focus during the pandemic

    Activity Description / Statement of Need:

    In this online, self-learning activity:

    The WHO defines vaccine hesitancy (VH) as a “delay in acceptance or refusal of vaccines despite the availability of vaccination services.” Despite substantial progress in rates of routine immunization over the decades prior to the most recent one, more recent trends suggest that immunization rates are beginning to plateau. Beyond VH and skepticism, there is also the embrace of outright vaccine rejection or denial fostered by the presence disinformation on conventional and social media platforms including claims that vacines are unsafe or unnecessary. Recent outbreaks of largely eradicated diseases such as measles, mumps, and diphtheria suggest that herd immunity may have suffered, putting those ineligible for vaccination at additional risk of infection. These developments have been attributed in part to VH and denial.

    One large group with increasing VH is parents. A 2019 national survey found that approximately 1 in 4 parents reported serious concerns towards vaccinating their children. Another study saw that in up to 35% parents of well-vaccinated children demonstrate VH. Parents may raise issues that many providers feel ill-equipped to answer, due to lack of thorough knowledge of all vaccines or lack of evidence-based communication strategies. Unfortunately, only few evidence-based strategies exist to guide providers in their discussions with vaccine-hesitant parents.

    Providers play a crucial role in vaccinating populations, but it is not and should not be their sole responsibility. Clinical practice sites, community organizations, health organizations, and government all contribute to addressing VH. Understanding potential solutions outside the office, such as media campaigns and policy changes, also provide insight into vaccine hesitancy and potential directions for future use.

    Target Audience:

    The following HCPs: Primary care physicians, pediatricians, and public health professionals; physician assistants, nurse practitioners, nurses, and pharmacists who practice in adult internal medicine and pediatrics; and any other clinicians who commonly encounter patients eligible for protection against vaccine-preventable diseases.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Material last updated: December 10, 2021
    • Expiration of CME credit: December 10, 2023
  • FREE

    Treatment of acute COVID-19 infection: shifting strategy evolving enemy

    Activity Description / Statement of Need:

    The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has upended life as humankind knows it, leading to over 238,000,000 cases and 4,800,000 deaths worldwide at the time of writing. SARS-CoV-2 targets the angiotensin-converting enzyme 2 (ACE-2) receptors present in the nasal epithelium and lungs. Viral replication leads to a variety of clinical presentations and outcomes during the acute infectious process, including: asymptomatic disease; milder symptoms such as fever, dry cough, shortness of breath, abdominal pain, anosmia, and ageusia; and, in severe cases, hypoxemia, acute respiratory stress disease, and death. Complications are not limited to the respiratory tract and may present as multi-organ involvement varying from acute cardiac injury, coagulopathies, and multisystem inflammatory syndrome. Some survivors of the disease must also grapple with reduced health-related quality of life as a result of chronic lung fibrosis and central nervous system or mental health dysfunction, including post-traumatic stress disease, attention deficit, anxiety, and overall impaired cognitive function.

    This learning activity has been designed to bring physicians knowledge of the strategies for the management of COVID-19 up to date and to improve their competence and performance in diagnosing and treating it.

    Target Audience:

    HCPs including: Hospitalists and other primary care physicians, infectious disease physicians, pulmonologists, and critical care physicians; physician assistants, nurse practitioners, and pharmacists in those areas of specialty; and any other healthcare professionals with an interest in or who clinically encounter patients with acute COVID-19 infection.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 01/30/2022
    • Expiration of CME credit: 01/30/2023
  • FREE

    PILOTforPulmonary.org: COVID-19 and Monoclonal Antibodies

    Designed for pulmonologists, infectious disease specialists, primary care physicians, nurse practitioners, PAs, and other health care providers who treat patients with COVID-19 and want to enhance their knowledge of monoclonal antibodies, this highly interactive learning activity features animations, faculty videos, downloadable resources, and more.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    • Format: Interacitve, Self-Directed, Animations, Videos, Slides